Biogen Names Michel Vounatsos Chief Executive Officer
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/13/2026
- S&P 500 ends higher as CoreWeave results fuel AI optimism
- Oil prices edge up as investors weigh US-Iran talks deadlock against lower demand
- CoreWeave soars after fifth straight quarter of record revenue, raised guide
- Four key things investors will watch in Nvidia's earnings next week
- Silver could surge to $90 as investment demand takes over, Citi says
- After-Hours Movers: CSCO, COHR, HLIT, CBRS, STUB, ENS
- After-Hours Movers: CRWV, NBIS, SMCI, LITE, CAVA, HRB
- After-Hours Movers: P, RIOT, BW, RKLB, HIMS, UPWK
- After-Hours Movers: TEAM, NET, TWLO, DOCS, FROG, DV, TTD, ABNB, DKNG, SG, RKT
- After-Hours Stock Movers: WDC, SNDK, FIG, APP, HUBS, SOUN, DASH, XYZ, Z, FLNC
Biogen (BIIB) New CEO Doesn't Change Outlook at Baird
December 20, 2016 12:21 PM ESTBaird analsyt Brian Skorney has no change in his outlook to his Biogen (NASDAQ: BIIB) outlook after the company announced a new CEO. The analsyt also notes his strong commercial background.
Skorney commented, "After a months-long CEO search, Biogen announced appointment of Michel... More
Mizuho Analyst Trys to Explain Why Biogen (BIIB) is Up Despite New CEO News
December 20, 2016 10:59 AM ESTMizuho analyst Salim Syed weighed in on Biogen (NASDAQ: BIIB) with shares trading up on the new CEO announcement; contrary to the view of many on the Street that shares would trade down on the notion M&A would be taken... More
New Biogen (BIIB) CEO Doesn't Take M&A Off the Table - BMO
December 19, 2016 5:42 PM ESTBMO Capital analyst M. Ian Somaiya weighed in on Biogen (NASDAQ: BIIB) after the company named Michel Vounatsos CEO. The analyst said the appointment doesn't take M&A off the table.
Somaiya commented, "We believe Michel Vounatsos brings significant commercial... More
